These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients. Hansteen V Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841 [TBL] [Abstract][Full Text] [Related]
7. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression. Shivkumar K; Schultz L; Goldstein S; Gheorghiade M Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974 [TBL] [Abstract][Full Text] [Related]
8. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771 [TBL] [Abstract][Full Text] [Related]
10. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group. Byington RP Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483 [TBL] [Abstract][Full Text] [Related]
11. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial. Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group. Peters RW; Byington RP; Barker A; Yusuf S J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377 [TBL] [Abstract][Full Text] [Related]
13. Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. Friedman LM; Byington RP; Capone RJ; Furberg CD; Goldstein S; Lichstein E J Am Coll Cardiol; 1986 Jan; 7(1):1-8. PubMed ID: 3510232 [TBL] [Abstract][Full Text] [Related]
14. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial. Byington RP; Curb JD; Mattson ME JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051 [TBL] [Abstract][Full Text] [Related]
15. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. Morganroth J; Lichstein E; Byington R Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736 [TBL] [Abstract][Full Text] [Related]
16. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience). Peters RW Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715 [TBL] [Abstract][Full Text] [Related]
17. The Beta-blocker Heart Attack Trial. Furberg CD Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615 [TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA; 1980 Feb; 243(7):661-9. PubMed ID: 6985998 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol. Kostis JB; Wilson AC; Sanders MR; Byington RP Am J Cardiol; 1988 May; 61(13):975-8. PubMed ID: 3284322 [TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]